CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
Titel:
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
Auteur:
Gönen, Mithat Sun, Zhuoxin Figueroa, Maria E. Patel, Jay P. Abdel-Wahab, Omar Racevskis, Janis Ketterling, Rhett P. Fernandez, Hugo Rowe, Jacob M. Tallman, Martin S. Melnick, Ari Levine, Ross L. Paietta, Elisabeth